Drugs Made In America Acquisition II Unit SEC Filings
NASDAQ: DMIIUFinancial ServicesShell CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Drugs Made In America Acquisition II Unit filing overview
This page lists 24 recent SEC filings by Drugs Made In America Acquisition II Unit (DMIIU), including 8 8-K, 6 4, 3 10-Q, 3 S-1/A. The latest annual report (10-K) was filed on Apr 15, 2026 for the period ending Dec 31, 2025. The most recent quarterly report (10-Q) was filed on Aug 14, 2026.
The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Apr 28, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
DMIIU SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Aug 14, 2026 | 10-Q | QUARTERLY REPORT | View on EDGAR |
| May 14, 2026 | 10-Q | QUARTERLY REPORT | View on EDGAR |
| Apr 28, 2026 | 8-K | Entry into a Material Definitive Agreement | View on EDGAR |
| Apr 15, 2026 | 10-K | ANNUAL REPORT | View on EDGAR |
| Apr 3, 2026 | 8-K | Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | View on EDGAR |
| Mar 17, 2026 | 8-K | Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement; Other Events | View on EDGAR |
| Mar 6, 2026 | 8-K | Departure or Appointment of Directors or Officers; Compensatory Arrangements | View on EDGAR |
| Mar 6, 2026 | 8-K | Other Events | View on EDGAR |
| Nov 18, 2025 | 8-K | Departure or Appointment of Directors or Officers; Compensatory Arrangements | View on EDGAR |
| Nov 18, 2025 | 10-Q | QUARTERLY REPORT | View on EDGAR |
| Oct 17, 2025 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Oct 2, 2025 | SCHEDULE 13D | Beneficial ownership report (activist) | View on EDGAR |
| Oct 2, 2025 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Oct 2, 2025 | 8-K | Other Events | View on EDGAR |
| Oct 1, 2025 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Oct 1, 2025 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Oct 1, 2025 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Oct 1, 2025 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 29, 2025 | 8-K | Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Departure or Appointment of Directors or Officers; Compensatory Arrangements; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Other Events | View on EDGAR |
| Sep 25, 2025 | 424B4 | PROSPECTUS SUPPLEMENT | View on EDGAR |
| Sep 16, 2025 | S-1/A | REGISTRATION STATEMENT | View on EDGAR |
| Sep 15, 2025 | S-1/A | REGISTRATION STATEMENT | View on EDGAR |
| Sep 5, 2025 | S-1/A | REGISTRATION STATEMENT | View on EDGAR |
| Jul 21, 2025 | S-1 | REGISTRATION STATEMENT | View on EDGAR |